Jiangzhong Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000M80
CNY
23.01
-0.34 (-1.46%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jiangzhong Pharmaceutical Co., Ltd.
Why is Jiangzhong Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 12.39% and Operating profit at 11.78% over the last 5 years
2
Negative results in Mar 25
  • INTEREST(HY) At CNY 1.69 MM has Grown at 9,936.31%
  • OPERATING CASH FLOW(Y) Lowest at CNY 953.22 MM
  • CASH AND EQV(HY) Lowest at CNY 2,737.57 MM
3
With ROE of 22.88%, it has a very attractive valuation with a 3.42 Price to Book Value
  • Over the past year, while the stock has generated a return of 12.41%, its profits have risen by 12.2% ; the PEG ratio of the company is 1.2
  • At the current price, the company has a high dividend yield of 5.6
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Jiangzhong Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jiangzhong Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Jiangzhong Pharmaceutical Co., Ltd.
-100.0%
-0.71
17.14%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.39%
EBIT Growth (5y)
11.78%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
1.05
Tax Ratio
15.82%
Dividend Payout Ratio
95.48%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
43.69%
ROE (avg)
16.29%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
3.42
EV to EBIT
12.82
EV to EBITDA
11.11
EV to Capital Employed
4.68
EV to Sales
2.80
PEG Ratio
1.20
Dividend Yield
5.59%
ROCE (Latest)
36.47%
ROE (Latest)
22.88%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
ROCE(HY)

Highest at 19.55%

RAW MATERIAL COST(Y)

Fallen by -3.57% (YoY

PRE-TAX PROFIT(Q)

Highest at CNY 358.41 MM

NET PROFIT(Q)

Highest at CNY 284.87 MM

EPS(Q)

Highest at CNY 0.45

-12What is not working for the Company
INTEREST(HY)

At CNY 1.69 MM has Grown at 9,936.31%

OPERATING CASH FLOW(Y)

Lowest at CNY 953.22 MM

CASH AND EQV(HY)

Lowest at CNY 2,737.57 MM

Here's what is working for Jiangzhong Pharmaceutical Co., Ltd.
Pre-Tax Profit
Highest at CNY 358.41 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 284.87 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.45
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost
Fallen by -3.57% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jiangzhong Pharmaceutical Co., Ltd.
Interest
At CNY 1.69 MM has Grown at 9,936.31%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY 953.22 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Cash and Eqv
Lowest at CNY 2,737.57 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents